Molecular neurosurgery: vectors and vector delivery strategies

Area of Science:

• Neurosurgery
• Gene Therapy
• Molecular Medicine

Background:

• Molecular neurosurgery utilizes vector-mediated gene therapy and gene knockdown to modify gene expression for treating neurological disorders.
• Current gene therapy approaches hold revolutionary potential for neurosurgery but face significant obstacles to clinical implementation.

Purpose of the Study:

• To review the current practice of molecular neurosurgery, emphasizing practical vector delivery techniques to the brain.
• To provide an overview of vectors used in clinical trials and past gene therapy trials.
• To highlight key areas for future research to advance gene therapy translation into clinical practice.

Main Methods:

• Review of current literature on molecular neurosurgery techniques.
• Focus on practical neurosurgical aspects of vector delivery to the brain.
• Analysis of viral and non-viral vectors for efficient cell transduction and reduced toxicity.

Main Results:

• Significant challenges persist in effective vector delivery to the brain and achieving efficient, non-toxic cell transduction.
• Various viral and non-viral vectors are being developed and tested for clinical applications.
• Past gene therapy clinical trials provide insights into efficacy and safety.

Conclusions:

• Overcoming challenges in vector delivery and vector safety is crucial for the clinical translation of molecular neurosurgery.
• Continued research into novel vectors and delivery strategies is essential for advancing gene therapy in neurosurgery.
• Successful translation of gene therapy into routine clinical practice requires addressing current research gaps.